Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Bully88on Apr 15, 2021 7:17am
191 Views
Post# 32998967

Multiple Revenue Streams

Multiple Revenue StreamsThe Following is from the Care oncology frequently asked questions

https://careoncology.com/faq/

The initial consultation is $925.00. The bundled-cash price of the medications from our partner pharmacy averages $60.00-$100.00 per month.

Follow ups are $330.00 every three months; for a total cost of $2,635 the first year. The subsequent annual costs total $2,040.


So as for revenue streams that are now in stage zero's control

1. Covid Testing

2.Consultations ( Initial + follow up)
3. Testing Aristotle + Colon Sentry + Breast Sentry + Prostate Health Index
4. pharmaceuticals

Now the fun begins.

If for one patient,  the revenue is roughly $2600 (excluding Testing)  multiply that by the 3000 patients currently enrolled =  $7,800,000  the first year

the second year at  roughly $2000 per patient (excluding testing) multiply that by 3000 patients currently enrolled = $6,000,000


That is what we can look forward to realising in the future.

Now as for how Aristotle can blow all of that out of the water is if we land this "big employer"

on an Anual basis  

 

Tests completed Price Revenue  Tests per day at 200 working days per year
100  $ 1,500.00  $              150,000.00 0.5
200  $ 1,500.00  $              300,000.00 1
300  $ 1,500.00  $              450,000.00 1.5
400  $ 1,500.00  $              600,000.00 2
500  $ 1,500.00  $              750,000.00 2.5
600  $ 1,500.00  $              900,000.00 3
700  $ 1,500.00  $          1,050,000.00 3.5
800  $ 1,500.00  $          1,200,000.00 4
900  $ 1,500.00  $          1,350,000.00 4.5
1000  $ 1,500.00  $          1,500,000.00 5
1100  $ 1,500.00  $          1,650,000.00 5.5
1200  $ 1,500.00  $          1,800,000.00 6
1300  $ 1,500.00  $          1,950,000.00 6.5
1400  $ 1,500.00  $          2,100,000.00 7
1500  $ 1,500.00  $          2,250,000.00 7.5
1600  $ 1,500.00  $          2,400,000.00 8
1700  $ 1,500.00  $          2,550,000.00 8.5
1800  $ 1,500.00  $          2,700,000.00 9
1900  $ 1,500.00  $          2,850,000.00 9.5
2000  $ 1,500.00  $          3,000,000.00 10
2100  $ 1,500.00  $          3,150,000.00 10.5
2200  $ 1,500.00  $          3,300,000.00 11
2300  $ 1,500.00  $          3,450,000.00 11.5
2400  $ 1,500.00  $          3,600,000.00 12
2500  $ 1,500.00  $          3,750,000.00 12.5
2600  $ 1,500.00  $          3,900,000.00 13
2700  $ 1,500.00  $          4,050,000.00 13.5
2800  $ 1,500.00  $          4,200,000.00 14
2900  $ 1,500.00  $          4,350,000.00 14.5
3000  $ 1,500.00  $          4,500,000.00 15
4000  $ 1,500.00  $          6,000,000.00 20
5000  $ 1,500.00  $          7,500,000.00 25
6000  $ 1,500.00  $          9,000,000.00 30
7000  $ 1,500.00  $        10,500,000.00 35
8000  $ 1,500.00  $        12,000,000.00 40
9000  $ 1,500.00  $        13,500,000.00 45
10000  $ 1,500.00  $        15,000,000.00 50
15000  $ 1,500.00  $        22,500,000.00 75
20000  $ 1,500.00  $        30,000,000.00 100
25000  $ 1,500.00  $        37,500,000.00 125
30000  $ 1,500.00  $        45,000,000.00 150
35000  $ 1,500.00  $        52,500,000.00 175
40000  $ 1,500.00  $        60,000,000.00 200
45000  $ 1,500.00  $        67,500,000.00 225
50000  $ 1,500.00  $        75,000,000.00 250


As you can see, things can add up verrrrry quickly.

With the right employer, and right plan. This could grow massive very easily.


I think Tripp has massive plans for this company and we will all be highly valued one day. 

What we are seeing, is this company in its infancy just getting started. 

Cheers,


Bully



 

<< Previous
Bullboard Posts
Next >>